Given Imaging Ltd. (NASDAQ: GIVN) todayannounced that Yuval Yanai, Chief Financial Officer of Given Imaging, willpresent at the Citigroup Healthcare Conference taking place February 27 -March 1 in Washington D.C. Mr. Yanai's presentation is scheduled forTuesday, February 28 at 10:20am ET.

To access a live webcast of Mr. Yanai's presentation, visitwww.givenimaging.com. A replay of the webcast will be available for thirtydays at the above referenced website.

About Given Imaging

Given Imaging is redefining gastrointestinal diagnosis by developing,producing and marketing innovative, patient-friendly products for detectinggastrointestinal disorders. The company is developing a complete line ofPillCam™ video capsules for detecting disorders of the gastrointestinaltract. The company's technology platform is the Given® Diagnostic System,featuring the PillCam video capsule, a disposable, miniature video cameracontained in a capsule, which is ingested by the patient. The PillCam™SB capsule is the only naturally ingested method for direct visualizationof the entire small intestine. It is currently marketed in the UnitedStates and in more than 50 other countries and has benefited more than300,000 patients worldwide. The PillCam™ ESO video capsule, whichprovides visual examination of the esophagus, has been cleared formarketing by the FDA. Additional capsules for visualization of the stomachand colon are under development. Given Imaging's headquarters,manufacturing and R&D facilities are located in Yoqneam, Israel; it hasdirect sales and marketing operations in the United States, Germany andFrance, and local offices in Japan, Spain and Australia. For moreinformation, visit http://www.givenimaging.com.

This press release contains forward-looking statements about Given Imaging,including projections about our business and our future revenues, expensesand profitability, within the meaning of Section 27A of the Securities Actof 1933 and Section 21E of the Securities Exchange Act of 1934. Forexample, statements in the future tense, words such as "anticipates,""estimates," "expects," "intends," "plans," "believes," and words and termsof similar substance used in connection with any discussion of futureoperating or financial performance identify such forward-lookingstatements. Those forward-looking statements are not guarantees of futureperformance and actual results could differ materially from our currentexpectations as a result of numerous factors, including but not limited tothe following: changes in regulatory environment, our success inimplementing our sales, marketing and manufacturing plan, protection andvalidity of patents and other intellectual property rights, the impact ofcurrency exchange rates, the effect of competition by other companies, theoutcome of future litigation, the reimbursement policies for our productfrom healthcare payors, quarterly variations in operating results, theimpact of the newly adopted SFAS 123R for expensing option-based payments,the possibility of armed conflict or civil or military unrest in Israel andother risks disclosed in our filings with the U.S. Securities and ExchangeCommission.

For further information contact:Fern LazarDavid CareyLazar Partners Ltd.Phone: (866) GIVEN IREmail ContactEmail Contact

Yuval YanaiGiven Imaging Ltd.

SOURCE: Given Imaging

Source: marketwire